Member Thought Leadership
MEMBER:
Russell Reynolds Associates
Yvonne Lu and Hayden Melecio consultants from Russell Reynolds Associates published new insights.
Market access is evolving into one of the most strategically important functions in pharma—impacting pricing, reimbursement, and ultimately determining whether a drug succeeds commercially.
With this recognition of strategic importance, biopharma companies are increasingly appointing global heads of value & access / chief market access officers to sit alongside commercial and medical leadership, sometimes reporting directly into the CEO.
